$SLN
Silence Therapeutics plc
Nasdaq · Healthcare · Pharmaceutical Preparations · London
SLN chart
What traders are saying about $SLN
Latest postsSilence Therapeutics plc news
- Silence Therapeutics stock surges on divesiran trial success
scanx.trade ·
- Silence Therapeutics plc (XRP2.F) Seasonal Returns Chart - Yahoo Finance
Yahoo! Finance Canada ·
- Silence Therapeutics PLC (XRP2.SG) Seasonal Returns Chart - Yahoo Finance
Yahoo! Finance Canada ·
- Silence Therapeutics closes $201.3 million upsized ADS offering
scanx.trade ·
- One holder reports no voting power over 13.2M Silence Therapeutics (SLN) shares.
Stock Titan ·
- What Sits Behind a 132.88% Monthly Gain at Bumble (NASDAQ:BMBL), Katapult (NASDAQ:KPLT) and Silence Therapeutics (NASDAQ:SLN)?
kalkine.ca ·
- Why Did Silence Therapeutics (NASDAQ:SLN) Climb 95.21% in a Month While Lyell Immunopharma (NASDAQ:LYEL), Teladoc Health (NYSE:TDOC), Jin Medical International (NASDAQ:ZJYL) and Capricor Therapeutics (NASDAQ:CAPR) Also Gained?
kalkine.ca ·
- Why Did Bumble (NASDAQ:BMBL) Post a 132.88% Monthly Gain, With Katapult (NASDAQ:KPLT), Silence Therapeutics (NASDAQ:SLN), Portillo's (NASDAQ:PTLO) and Universal Logistics (NASDAQ:ULH) Also Rising?
kalkine.ca ·
- Silence Therapeutics plc (SLN) stock price, news, quote and history
Yahoo Finance Singapore ·
- Silence Therapeutics data accepted for ASH presentation
Investing.com ·
- Silence Therapeutics Announces Oral Presentation on SANRECO Phase 2 Study of Divesiran in Polycythemia Vera at ASH 2026
Yahoo Finance ·
- A Phase 3 Win and a 130% Takeover Premium Lit Up Rare Blood-Disease Stocks on Monday
Yahoo Finance ·
Silence Therapeutics plc key financials
| USD | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Revenue | $559,000 | $43.3M | $31.6M | $21.7M |
| Net income | -$88.6M | -$45.3M | -$54.2M | -$50.3M |
| Diluted EPS | $-0.63 | $-0.33 | $-0.49 | $-0.52 |
| Total assets (year end) | $131.4M | $202.6M | $119.4M | – |
| Cash and equivalents (year end) | $11.3M | $121.3M | $68.8M | – |
Calendar-year figures as reported to the SEC in XBRL filings.
Recent SEC filings
About Silence Therapeutics plc
- Ticker
- SLN (Nasdaq)
- Industry
- Pharmaceutical Preparations
- Headquarters
- London
- Incorporated in
- United Kingdom
- SEC CIK
- 1479615
Frequently asked questions
What exchange is Silence Therapeutics plc listed on?
Silence Therapeutics plc trades on the Nasdaq under the ticker symbol SLN.
What industry is Silence Therapeutics plc in?
Silence Therapeutics plc is classified by the SEC under "Pharmaceutical Preparations", part of the Healthcare sector on StockTweeting.
Where is Silence Therapeutics plc headquartered?
Silence Therapeutics plc's business address on file with the SEC is in London.
How much revenue did Silence Therapeutics plc report?
Silence Therapeutics plc reported $559,000 in revenue for calendar year 2025, according to its SEC filings.